Evaluation and treatment of an unusual urachal mass: a case report by unknown
a SpringerOpen Journal
Cooper et al. SpringerPlus  (2015) 4:18 
DOI 10.1186/s40064-014-0782-9CASE STUDY Open AccessEvaluation and treatment of an unusual urachal
mass: a case report
John L Cooper*, Nikolai A Sopko and Trinity J BivalacquaAbstract
Abnormalities of the urachus, the vestigial remnant of the allantois, result when the embryonic lumen fails to
completely obliterate during fetal development. In adults, urachal abnormalities are most commonly masses,
with urachal adenocarcinoma representing the most frequent etiology. Due to the low incidence of urachal masses,
guidelines for diagnostic workup and treatment are based off of a limited body of evidence comprised primarily
of case reports and retrospective series. We present the case of a fifty-two-year-old woman with a urachal mass.
Full radiologic workup consisting of computed tomography, cystoscopy and ultrasonography is included, and the
risk factors, treatment and prognosis are discussed.
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Urachal masses are exceedingly rare in the general popu-
lation and can arise from a wide variety of causes. One
retrospective epidemiological study of 33 adult patients
with urachal masses found that 67% of cases were
caused by carcinoma, most commonly adenocarcinoma,
while the remaining 33% were due to benign etiologies
including abscesses and cysts (Tian et al. 2008). Urachal
adenocarcinoma comprises approximately 0.34% of all
bladder neoplasms with only several hundred cases re-
ported in the literature (Pinthus et al. 2006; Manunta
et al. 2005). Unfortunately, the prognosis associated with
urachal adenocarcinoma is poor, with 5-year disease-
specific survival ranging from 40% to 61.3% underscor-
ing the need for accurate diagnosis to properly treat and
counsel the patient (Siefker-Radtke et al. 2003; Ashley
et al. 2006). We report the evaluation and treatment of a
urachal mass in a fifty-two-year-old woman and discuss
the risk factors, treatment rationale and implications for
her prognosis.Case presentation
A fifty-two-year-old woman with a history of poorly con-
trolled Type II Diabetes Mellitus and depression presented* Correspondence: jcoope45@jhmi.edu
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fevers to 39.2°C and was found to be in diabetic ketoacido-
sis. During her stay in the ICU, she began to complain of
pain below her umbilicus. She denied the presence of
hematuria, umbilical drainage, or any other urinary symp-
toms. Her surgical history included a hysterectomy in the
1980’s and sacral nerve stimulator placement in the early
2000’s. On physical examination she was found to have a
large rash in her perivaginal area and a small, palpable
mass with induration and tenderness in the location of
her periumbilical pain. A well-healed surgical scar from
her prior hysterectomy was noted at the site of pain, but
there was no erythema or drainage present. A CT scan of
her abdomen and pelvis was obtained, which demon-
strated a 5.3 × 8.8 × 12.6 cm rim-enhancing, loculated
soft-tissue mass extending from the anterior dome of the
bladder to the lower anterior abdominal wall and invading
the rectus abdominis muscles, concerning for urachal
carcinoma vs. urachal cyst abscess (Figure 1).
Ultrasonography further characterized the mass as het-
erogeneous with both cystic and solid components, and
revealed that there was not a drainable pocket (Figure 2).
An ultrasound-guided fine needle aspiration was ob-
tained for gross pathology, cytopathology and microbio-
logic analysis of the mass. These studies demonstrated
marked acute inflammation, rare amounts of Candida
krusei present, no evidence of bacteria, and no cyto-
logical or gross evidence of malignancy. Her blood andan Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
Figure 1 CT scan of the abdomen and pelvis, axial (left) and sagittal (right) views. The mass can be seen extending anteriorly and
superiorly from the dome of the bladder (arrows).
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negative for enteric bacteria or fungi, and her fever had
dissipated.
At this time it was unclear whether the biopsy results
from the mass demonstrated a fungal abscess, contamin-
ation from the skin or her pelvic rash, or a superinfected
urachal adenocarcinoma. Infectious Diseases recommended
empiric antibiotic coverage against gram-negative enteric
flora with ciprofloxacin and metronidazole. She then un-
derwent cystoscopy as an outpatient to evaluate for the
presence of a vesico-urachal fistula. Significant purulent
drainage was seen exuding from the dome of the bladder
with surrounding areas of bullous edema Biopsy of the
areas demonstrated chronic inflammation and polypoid
cystitis, and the drainage of the mass was attempted.
Repeat CT and pelvic ultrasound were performed to
reassess the size and characteristics of the mass and fur-
ther evaluate the location and presence of the fistula
tract. These studies revealed that the mass was signifi-
cantly smaller with maximal dimension of 3.7 cm, and
the vesico-urachal fistula tract was visualized extending
from the inferior portion of the mass to the bladder.Figure 2 Ultrasonography of the upper pelvis, transverse (left) and sa
to the bladder, which is decompressed with a Foley catheter.More distinct regions were seen within the mass; the
superior aspect had the heterogeneous appearance of a
solid tumor with central liquefactive necrosis while the
inferior region was consistent with a mature abscess
(Figure 3).
Based on the results of these imaging studies, the etiology
of the mass was thought to be either a superinfected ura-
chal adenocarcinoma with bladder involvement and sec-
ondary abscess formation or a primary urachal abscess with
fistula. She was placed on intravenous antibiotics and anti-
fungals without clinical improvement. She subsequently
underwent surgical removal of the mass, umbilicus and
abdominal wall with partial cystectomy as a joint case
between Urology and General Surgery. Tissues from the
mass, bladder and abdominal wall sent for pathologic ana-
lysis revealed acute and chronic inflammation, a soft tissue
fistula tract with fibrosis, focal abscess formation and no
evidence of malignancy. At this time the final diagnosis of a
fungal-infected urachal sinus was made, and she was given
a peripherally inserted central catheter and placed on an
outpatient regimen of Micafungin and Ertapenem for anti-
fungal and antibacterial coverage. She was followed upgittal (right) views. The heterogeneous mass (arrows) lies superficial
Figure 3 CT scan (left) and Ultrasound (right) of the pelvis. These studies demonstrate a smaller, heterogeneous mass (arrows) with a solid
superior compartment and a walled-off, phlegmon-filled inferior compartment.
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and General Surgery, and all drains and catheters were re-
moved with no post-surgical complications.
Discussion
Urachal masses have a very low prevalence in the popula-
tion and are rarely seen in clinical practice. Thus, there
are few guidelines for the evaluation, diagnosis and treat-
ment of these cases. Although the majority of masses are
malignant, benign causes are also seen including abscess
as in the above case. It is important to understand how to
discern between benign and malignant etiologies in order
to promptly initiate proper treatment, reduce the perform-
ance of unnecessary surgeries in benign, non-infectious
cases, and accurately inform patients of their prognosis.
However, making a definitive pre-operative diagnosis of
urachal masses is often difficult, due in part to the sparse
amount of data describing the typical clinical and radio-
logic findings that could be used to distinguish between
benign and malignant causes. In fact, one study demon-
strated that no diagnostic test was accurate enough to
preclude the surgical removal of a urachal mass of unknown
etiology (Meeks et al. 2013).
Certain presenting symptoms have been shown to be
more common in benign versus malignant urachal masses.
While the most frequent symptom associated with urachal
carcinoma is gross hematuria, benign etiologies, including
abscesses and cysts, most commonly present with a palp-
able abdominal mass (Tian et al. 2008; Manunta et al.
2005; Ashley et al. 2006). There have been several similar
cases reported in the literature of urachal abscesses that
mimicked neoplasms on physical exam, CT and ultra-
sound, all of which were able to be diagnosed only follow-
ing partial cystectomy and en bloc mass resection (Chen
et al. 1992). A retrospective study described the most com-
mon features on CT scans of patients with proven cases of
urachal adenocarcinoma to determine whether malignant
cancers could be distinguished radiographically from be-
nign or infectious masses. The majority of these tumors
were characterized on CTas midline, supravesicular, mixedsolid and cystic, calcified and frequently invading the blad-
der wall (Thali-Schwab et al. 2005).
These results help explain the difficulty and complex-
ity of the diagnosis in the above case, as the patient’s
mass was midline, supravesicular and had a mixed solid
and cystic appearance. However, this patient has several
additional risk factors for having a fungal abscess rather
than adenocarcinoma, most notably a history of un-
controlled diabetes, a pelvic fungal rash, and a midline
periumbilical surgical scar that could have served as a
portal of entry for her infection. Follow-up for urachal
masses is dependent on the etiology. Malignant causes re-
quire extensive follow-up, whereas non-malignant causes
removed surgically are generally considered resolved once
removed and generally do not require additional follow-up
other than that expected for post-operative care.
Ultimately, the final diagnosis of a benign versus ma-
lignant urachal mass has implications on treatment and
overall outcomes. Urachal adenocarcinoma carries a par-
ticularly grave prognosis in most circumstances (Pinthus
et al. 2006; Siefker-Radtke et al. 2003; Ashley et al.
2006). It is important to properly inform patients with
cancer of the reality of their disease, while alleviating the
concerns of those patients with a more benign etiology.
Standard therapy for either malignant or benign urachal
masses based on both prospective and retrospective evi-
dence includes en bloc resection with or without partial
cystectomy (Herr et al. 2007). The need for adjuvant
therapies and long-term follow-up varies depending on
the etiology (Meeks et al. 2013; Herr et al. 2007). Patients
with adenocarcinoma require additional evaluation for dis-
ease monitoring, whereas this patient required an intra-
venous antifungal regimen and post-operative follow-up.
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